NCAB Says President’s Budget Would “Seriously Damage” Cancer Program
In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says
Biology Societies Recomend 15% Funding Increase for NIH
Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says
Letter to The Editor: IOM Panel Urges Greater Integration Of Research
Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State